These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15979322)

  • 21. Pneumonectomy for lung cancer in heart transplant recipient.
    Strauch JT; Aleksic I; Baryalei MM; Dalichau H
    Thorac Cardiovasc Surg; 2001 Jun; 49(3):187-8. PubMed ID: 11432481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.
    Serraino D; Piselli P; Busnach G; Burra P; Citterio F; Arbustini E; Baccarani U; De Juli E; Pozzetto U; Bellelli S; Polesel J; Pradier C; Dal Maso L; Angeletti C; Carrieri MP; Rezza G; Franceschi S;
    Eur J Cancer; 2007 Sep; 43(14):2117-23. PubMed ID: 17764927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary neoplasms as a consequence of transplantation and cancer therapy.
    Penn I
    Cancer Detect Prev; 1988; 12(1-6):39-57. PubMed ID: 3052837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.
    Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V
    Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.
    Fernández FG; Jaramillo A; Ewald G; Rogers J; Pasque MK; Mohanakumar T; Moazami N
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S255-61. PubMed ID: 15993782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study.
    Tessari G; Naldi L; Boschiero L; Cordiano C; Piaserico S; Fortina AB; Cerimele D; La Parola IL; Capuano M; Gotti E; Ruggenenti P; Sassi F; Remuzzi G; Girolomoni G
    Eur J Dermatol; 2006; 16(5):553-7. PubMed ID: 17101478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignancies in recipients of organ transplants.
    Penn I
    Johns Hopkins Med J Suppl; 1974; 3():211-21. PubMed ID: 4608179
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion.
    Cardell M; Jung FJ; Zhai W; Hillinger S; Welp A; Manz B; Weder W; Korom S
    J Pineal Res; 2008 Apr; 44(3):261-6. PubMed ID: 18339121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
    Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
    J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancers after renal transplantation.
    Wong G; Chapman JR
    Transplant Rev (Orlando); 2008 Apr; 22(2):141-9. PubMed ID: 18631867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoplastic consequences of transplantation and chemotherapy.
    Penn I
    Cancer Detect Prev Suppl; 1987; 1():149-57. PubMed ID: 3480049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malignant tumors under immunosuppression, new problem in transplant recipients].
    Enderlin F; Guisan Y
    Schweiz Rundsch Med Prax; 1973 Aug; 62(34):1031-5. PubMed ID: 4582307
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of neoplastic disease in cardiac allograft recipients.
    Savasta M; Lentini S
    Rev Cardiovasc Med; 2011; 12(4):219-26. PubMed ID: 22249512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignancies in renal transplantation: an unmet medical need.
    Dantal J; Pohanka E
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
    Otley CC; Griffin MD; Charlton MR; Edwards BS; Neuburg M; Stasko T;
    Br J Dermatol; 2007 Dec; 157(6):1183-8. PubMed ID: 17916206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
    Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.